Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Neuropsychopharmacol ; 13(4): 273-9, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12888187

ABSTRACT

Phencyclidine (PCP) has been described to exacerbate psychotic symptoms in patients suffering from schizophrenia. In rats, PCP, dose-dependently, induces hyperactivity, stereotyped behaviour and social isolation, postulated to represent the positive (hyperactivity, stereotypy) and negative (social isolation) symptoms of schizophrenia. Based on previous studies, ibotenic acid lesions in the amygdala on day 7 of life have been proposed as an animal model of psychiatric neurodevelopmental disorders like schizophrenia. The purpose of the present study was to determine whether the responsiveness to PCP on locomotor activity in animals lesioned in the amygdala on day 7 of life is different from the response to this drug in sham-operated animals. The effect of graded doses of PCP on behaviour was assessed in a small open field. Animals lesioned in the amygdala on day 7 of life appeared to be hyperresponsive to PCP compared to sham-operated animals. The hyperresponsiveness to PCP in rats lesioned in the amygdala on day 7 of life further contributes to the validation of this putative animal model of schizophrenia.


Subject(s)
Amygdala/injuries , Drug Hypersensitivity/etiology , Excitatory Amino Acid Antagonists/adverse effects , Phencyclidine/adverse effects , Schizophrenia/physiopathology , Animals , Animals, Newborn , Behavior, Animal/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Early Ambulation/veterinary , Exploratory Behavior , Habituation, Psychophysiologic/drug effects , Hyperkinesis , Male , Motor Activity , Rats , Rats, Wistar , Schizophrenia/chemically induced , Stereotyped Behavior
SELECTION OF CITATIONS
SEARCH DETAIL
...